Objectives

After participating in this educational activity, attendees should be able to:
1. Discuss current guideline recommendations for duration of DAPT after PCI.
2. Assess current literature for duration of DAPT after PCI.
3. Evaluate the strengths and limitations of the STOPDAPT-2 trial.

Faculty

Mariela Cardona Gonzalez, PharmD 
PGY1 Pharmacy Resident
Pharmacist
Baystate Medical Center 

None of the members of the faculty and planning committee for this educational event have commercial relationships with any entity producing, marketing, re-selling or distributing health care goods and services consumed by or used on patients.